Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3 | 0 | 11 | 355 | 253 |
| Gross Profit | 3 | N/A | 11 | 355 | 253 |
| Operating Expenses | 1,985 | 2,035 | 1,804 | 1,761 | 1,357 |
| Operating Income | -1,982 | -2,035 | -1,793 | -1,406 | -1,103 |
| Interest Expense | 389 | 900 | 284 | 322 | 319 |
| Other Income | 1,826 | 1,776 | 1,272 | 1,620 | 726 |
| Pre-tax Income | -544 | -1,158 | -805 | -107 | -697 |
| Income Tax | 1 | N/A | 7 | 5 | 31 |
| Net Income Continuous | -545 | -1,158 | -811 | -112 | -728 |
| Net Income | $-545 | $-1,158 | $-811 | $-112 | $-728 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.01 | -0.01 | N/A | N/A |
| EBITDA(a) | $-1,980 | $-2,033 | $-1,790 | $-1,403 | $-1,101 |